Keyphrases
Acute Myocardial Infarction
100%
Thrombolytic Therapy
69%
Streptokinase
36%
Tissue Plasminogen Activator (t-PA)
31%
Recombinant Tissue Plasminogen Activator (rt-PA)
24%
GUSTO
24%
Heparin
19%
Thrombolysis
19%
Reinfarction
15%
Mortality Rate
13%
Odds Ratio
13%
Myocardial Infarction
12%
Israel
11%
Baseline Characteristics
11%
Confidence Interval
10%
Infarction
10%
Alteplase
10%
ST Elevation
10%
Coronary Artery
9%
Patency
8%
Symptom Onset
8%
Clinical Characteristics
7%
ST Depression
7%
Coronary Angiography
6%
Clinical Outcomes
6%
Patient Management
6%
Angina
6%
ST-segment Elevation
6%
Mobile Intensive Care Unit
6%
Ischemia
6%
Coronary Angioplasty
6%
Angioplasty
6%
Hospital Mortality
6%
Intracranial Hemorrhage
5%
30-day Mortality
5%
Elderly Patients
5%
Prognostic Significance
5%
1-year Mortality
5%
Revascularization
5%
Improved Survival
5%
Infarct
5%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Heart Infarction
82%
Fibrinolytic Agent
62%
Streptokinase
33%
Tissue Plasminogen Activator
25%
Alteplase
23%
Heparin
20%
Infarction
18%
Heart Infarction
15%
Mortality Rate
14%
Hospital Mortality
12%
Ischemia
9%
Symptom
6%
Brain Hemorrhage
6%
Anterior Myocardial Infarction
5%
Inferior Myocardial Infarction
5%
Medicine and Dentistry
Acute Heart Infarction
56%
Fibrinolytic Therapy
35%
Blood Clot Lysis
14%
Infarction
12%
Alteplase
12%
Electrocardiogram
12%
Thrombolytic Drug
11%
Tissue Plasminogen Activator
10%
Streptokinase
9%
Inferior Myocardial Infarction
9%
Transluminal Coronary Angioplasty
8%
Angioplasty
8%
ST Elevation
7%
Artery
7%
Odds Ratio
7%
Apoplexy
7%
Heparin
7%
ST Segment Depression
7%
Mortality Rate
6%
Cerebral Hemorrhage
6%
Q Wave
6%
Revascularization
5%
Coronary Artery
5%
Intensive Care Unit
5%
Coronary Angiography
5%
Elderly Patient
5%
Symptom
5%
Myocardial Infarction
5%
Anterior Myocardial Infarction
5%